Advisory Services Network’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Advisory Services Network’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8	Closed	-$385	–	3513
2026 Q1	$385	Buy	+8	New	+$354	﹤0.01%	4464
2023 Q2	–	Sell	-100	Closed	-$1.08K	–	2627
2023 Q1	$1.08K	Hold	100	–	–	﹤0.01%	3598
2022 Q4	$1.5K	Buy	+100	New	+$1.46K	﹤0.01%	3516
2021 Q3	–	Sell	-701	Closed	-$10K	–	2397
2021 Q2	$10K	Buy	+701	New	+$10.6K	﹤0.01%	2790
2021 Q1	–	Sell	-701	Closed	-$12K	–	2207
2020 Q4	$12K	Hold	701	–	–	﹤0.01%	2348
2020 Q3	$11K	Buy	+701	New	+$13.2K	﹤0.01%	2378

Other funds holding KNSA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

Advisory Services Network's KNSA Position: Q2 2026 in Review

Advisory Services Network sold out of Kiniksa Pharmaceuticals (KNSA) in Q2 2026, closing a stake of 8 shares — an estimated $385 sold.

Advisory Services Network first reported a position in KNSA in Q3 2020 and held it in 6 quarters. The position peaked at $12K in Q4 2020. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

Advisory Services Network reported no remaining Kiniksa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 8 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $385.
Advisory Services Network first reported a position in Kiniksa Pharmaceuticals in Q3 2020 and held it in 6 quarters.
Advisory Services Network's Kiniksa Pharmaceuticals position peaked at $12K in Q4 2020.
266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.